Magnetic resonance imaging (MRI) has been proposed to have a role in predicting final
pathologic response when undertaken early during neoadjuvant chemotherapy (NAC) in …

Objectives To assess whether magnetic resonance imaging (MRI) can identify pre-treatment
differences or monitor early response in breast cancer patients receiving neoadjuvant …

Purpose To evaluate the relevance of breast cancer subtypes for magnetic resonance
imaging (MRI) markers for monitoring of therapy response during neoadjuvant …

Background The main purpose was to investigate the correlation between magnetic
resonance imaging (MRI)-based response patterns halfway through neoadjuvant …

BACKGROUND: Increased pathologic complete response (pCR) rates observed with
neoadjuvant chemotherapy (NCT) for some subsets of patients with invasive breast cancer …

Background This study assessed whether magnetic resonance imaging (MRI) could
accurately predict pathologic complete response (pCR) after neoadjuvant chemotherapy …

A pathological complete response (pCR) to neoadjuvant chemotherapy (NAC) is a signature
of favorable prognosis in breast cancer. The aim of this study was to assess the accuracy of …

We performed a systematic review and a meta-analysis of studies using MRI-radiomics for
predicting the pathological complete response in breast cancer patients undergoing …

Purpose To evaluate which factors may influence magnetic resonance imaging (MRI)
performance in the detection of pathologic complete response (pCR) after neoadjuvant …

Background There is an increasing need to develop a more accurate prediction model for
pathologic complete response (pCR) after neoadjuvant chemotherapy (NAC) in breast …